The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease - Steffel, J; Eikelboom, J W; Anand, S S; Shestakovska, O; Yusuf, S; Fox, K AA (Circulation, 2020)
[Erratum in: Circulation. 2020 Jul 7;142(1):e23. PMID: 32436455]